Creative Biolabs-Immuno-oncology

Anti-CCL2 (clone 1G.3.1G) SynExpress T7-R-P-E Engineered Tregs (CAT#: ITS-1224-CR305)

DatasheetDatasheet
Description
This product utilizes Engineered Tregs that have been engineered with our proprietary GeneCircuit technology to specifically target CCL2 (clone 1G.3.1G). We employs the Lentivirus (T7-RFP-PAX-EcoRI) vector components and the SynExpress system of the Coding regions Deletion/Delayed feedback for a robust and sustained response against cancers.
Host
human
Target
CCL2
Clone
1G.3.1G
Species Reactivity
human
Cell Source
Engineered Tregs
Sensor Gene
RFP
Promoter
T7
Effector Gene
PAX
Insertion Sites
EcoRI
Gene Modification
Deletion
Modification Domain
Coding regions
Carrier Type
Lentivirus
Transformation Accuracy
0.86
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving